Jazz Pharmaceuticals (JAZZ) EVP & Chief Legal Officer Neena Patil Sells Shares

What Happened
Neena M. Patil, Executive Vice President and Chief Legal Officer of Jazz Pharmaceuticals (JAZZ), disposed of 1,192 shares in an open-market sale on May 28, 2026 at $236.97 per share, for a total of $282,468. This was a sale (not a purchase) and, per the filing, was executed automatically under a pre-established plan.

Key Details

• Transaction date and price: 2026-05-28 at $236.97 per share.
• Total value: $282,468.
• Transaction type: Sale (Form 4 code S).
• Plan/footnote: Executed pursuant to a 10b5-1 trading plan adopted by the reporting person on February 26, 2026; the transaction occurred automatically and was not discretionary (Footnote F1).
• Shares owned after transaction: Not disclosed in the provided filing.
• Filing timeliness: Report filed 2026-06-01 — appears timely (within the two business-day Form 4 filing window).

Context
Sales by executives can be routine (for diversification, liquidity, tax reasons, or via pre-set plans) and do not, by themselves, indicate a change in company outlook. Because this sale was made under a 10b5-1 plan and was automatic, it likely reflects a pre-arranged disposition schedule rather than a discretionary trade by the insider.